Nutrition in gastrointestinal diseases

2020 ◽  
pp. 621-678
Keyword(s):  
Inflammatory Bowel Disease ◽  
Irritable Bowel Syndrome ◽  
Small Intestine ◽  
Coeliac Disease ◽  
Bowel Disease ◽  
Lactose Intolerance ◽  
Gastrointestinal Diseases ◽  
Inflammatory Bowel ◽  
Irritable Bowel

Mouth, Dental, Oesophageal, Stomach, Gastrectomy, Small intestine, Malabsorption, Steatorrhoea, Lactose intolerance, Inflammatory bowel disease, Coeliac disease, Fistulae, stoma, transplantation, Irritable bowel syndrome, colon, Gallbladder

scholarly journals Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome

2018 ◽  
Vol 10 (472) ◽  
pp. eaap8914 ◽  
Author(s):  
Arnau Vich Vila ◽  
Floris Imhann ◽  
Valerie Collij ◽  
Soesma A. Jankipersadsing ◽  
Thomas Gurry ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Irritable Bowel Syndrome ◽  
Gut Microbiota ◽  
Bowel Disease ◽  
Gastrointestinal Diseases ◽  
Control Analysis ◽  
Microbiota Composition ◽  
Inflammatory Bowel ◽  
Irritable Bowel ◽  
Gut Microbiota Composition

Changes in the gut microbiota have been associated with two of the most common gastrointestinal diseases, inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). Here, we performed a case-control analysis using shotgun metagenomic sequencing of stool samples from 1792 individuals with IBD and IBS compared with control individuals in the general population. Despite substantial overlap between the gut microbiome of patients with IBD and IBS compared with control individuals, we were able to use gut microbiota composition differences to distinguish patients with IBD from those with IBS. By combining species-level profiles and strain-level profiles with bacterial growth rates, metabolic functions, antibiotic resistance, and virulence factor analyses, we identified key bacterial species that may be involved in two common gastrointestinal diseases.

Nutrition in gastrointestinal diseases

2011 ◽  
pp. 561-609
Keyword(s):  
Inflammatory Bowel Disease ◽  
Small Intestine ◽  
Coeliac Disease ◽  
Bowel Disease ◽  
Dental Health ◽  
Intestinal Failure ◽  
Gastrointestinal Diseases ◽  
Short Bowel ◽  
Inflammatory Bowel ◽  
Stomach Surgery

Mouth disorders 562 Dental health 564 Oesophageal disorders 566 Stomach disorders 570 Gastrectomy and stomach surgery 574 Small intestine disorders: introduction 577 Malabsorption: introduction 578 Steatorrhoea 580 Lactose intolerance 584 Inflammatory bowel disease 588 Coeliac disease 592 Intestinal failure and short bowel syndrome 596 Fistulae ...

scholarly journals Probiotics – between offer and confirmation

2016 ◽  
Vol 63 (1) ◽  
pp. 73-75
Author(s):  
Loredana Piloff ◽  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Helicobacter Pylori ◽  
Atopic Dermatitis ◽  
Irritable Bowel Syndrome ◽  
Food Safety ◽  
Bowel Disease ◽  
Lactose Intolerance ◽  
Regulatory Agencies ◽  
Inflammatory Bowel ◽  
Irritable Bowel

The significant increase (35-67%) of sales of probiotics requires an analysis of the justification for this use in relation to the evidence supported studies. EFSA (European Food Safety Authority) supports their efficiency potential, but warns that they are insufficient proven cause-effect relationship yet. Recommendation of these preparations are made for: gastroenteritis, diarrhea associated with antibiotics, lactose intolerance, atopy in children, atopic dermatitis, inflammatory bowel disease, irritable bowel syndrome, necrotizing enterocolitis, bacterial vaginosis, as an adjuvant in dyslipidemia, gastroduodenitis with Helicobacter pylori. According to records of current research results they are needed new data from the main regulatory agencies (FDA and EFSA) to guide treatment recommendations for probiotics.

Sign in / Sign up

Export Citation Format

Share Document